Alimentiv

Alimentiv is a global contract research organization (CRO) specifically focused on clinical research and drug development within the therapeutic areas of gastroenterology and hepatology. The company offers a comprehensive range of services designed to support pharmaceutical, biotechnology, and medical device companies throughout all phases of clinical trials. Their expertise encompasses study design and protocol development, clinical operations, data management, biostatistics, medical writing, and regulatory affairs. Alimentiv is particularly recognized for its deep scientific and clinical understanding of complex gastrointestinal and liver conditions, including inflammatory bowel disease (IBD), non-alcoholic steatohepatitis (NASH), and other digestive disorders. This specialization allows them to provide highly tailored and efficient solutions for their clients. With a strong global operational footprint, including significant presence across Europe in countries such as Germany, Poland, Romania, and the United Kingdom, Alimentiv leverages its specialized knowledge to advance therapeutic innovations and accelerate the development of new treatments for patients worldwide.

Last researched: 3/28/2026

0 of 2 listings flagged by automated signals